The 2021 scenario in targeted therapies for metastatic hepatobiliary and esophageal and gastric cancer
The 2021 scenario in targeted therapies for metastatic hepatobiliary and esophageal and gastric cancer
Ramon Andrade Bezerra De Mello
Maria Thereza Mansur Starling
